BofA Securities Explains IPHI Strategic and Tactical Benefit to Marvell (MRVL), PT Raised to $60 at
Tweet Send to a Friend
BofA Securities analyst Vivek Arya raised the price target on Marvell (NASDAQ: MRVL) to $60.00 (from $58.00) after incorporating the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
